Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.

Onglyza Heart Failure Injuries Lawsuits Centralized

by

Onglyza Heart Failure Injuries Lawsuits Centralized. Recently, the U.S. Judicial Panel on Multidistrict Litigation (JPML) has ordered that all filed federal Onglyza heart failure injuries lawsuits be consolidated and centralized as part of multidistrict litigation or MDL.

Type 2 diabetic patients who used Onglyza and developed heart problems allegedly caused by the diabetes drug will be consolidated in the U.S. District Court Eastern District of Kentucky, before U.S. District Judge Karen Caldwell.

What is an MDL?

MDL, or multidistrict litigation, is common in complex pharmaceutical and medical device product liability litigation, where a large number of individuals allege similar injuries following use of the same medication or medical device. The MDL process is designed to streamline the litigation process, reduce the time to trial and be a more efficient use of court resources since all of the plaintiffs and defendants are under one roof.

Onglyza Heart Failure Injuries Federal Litigation

There are about 100 personal injury and product liability lawsuits pending in the federal court system. All of the lawsuits have similar allegations that the manufacturer AstraZeneca failed to adequately warn about the potential heart failure side effects of Onglyza.

What is Onglyza?

Onglyza (Saxagliptin), made by Bristol-Myers Squibb and AstraZeneca, is used for the treatment of Type 2 diabetes. Onglyza belongs to a new class of diabetic drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors.

What are DiPeptidyl Peptidase 4 Inhibitors?

Dipeptidyl peptidase 4 inhibitors are oral antidiabetes medications that help control blood sugar levels in Type 2 diabetes patients. They block the enzyme dipeptidyl peptidase 4 and regulate the levels of insulin the body produces after a meal.

Dipeptidyl peptidase 4 inhibition results in increased activity of incretins, which blocks glucagon release. This leads to increased insulin release, slows gastric emptying and reduces blood sugar levels.

What is the problem with Onglyza?

Onglyza was cleared for sale by the FDA for treatment of type 2 diabetes in 2009, but over the last few years, many experts have expressed concern over heart safety, leading the FDA to require stronger label warnings about the increased risk of heart failure and other heart complications.

Plaintiffs blame AstraZeneca for the increased risk of heart failure, furthermore, they allege that the multinational pharmaceutical giant knew or should have known about the Onglyza heart risks for years, yet failed to adequately warn users and the doctors about the diabetes drug’s heart failure risks.

ONGLYZA HEART FAILURE INJURIES LAWSUIT

If you or a loved one has taken Onglyza and suffered heart failure and/or death, you may have a case for compensation against AstraZeneca. To learn more about your legal rights, call Dr. Shezad Malik Law Firm at 214-390-3189 for a free case review. Dr. Shezad Malik Law Firm is based in Dallas, Texas and is investigating and accepting Onglyza Heart Failure Injury cases nationwide.

Read more here

Texas Onglyza Heart Failure Lawsuit

Contact Information
3216 Tearose Dr
Richardson, TX 75082
Local: 214-390-3189Fax: 214-501-5660
If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of "Fair Use" and legitimately infringes on yours or your clients copyright we may be contacted concerning copyright matters at the addresses above.
In accordance with section 512 of the U.S. Copyright Act our contact information has been registered with the United States Copyright Office. "Safe Harbor" noticing procedures as outlined in the DMCA apply to this website concerning all 3rd party posts published herein. If notice is given of an alleged copyright violation we will act expeditiously to remove or disable access to the material(s) in question. It is our strict policy to disable access to accounts of repeat copyright violators. All 3rd party material posted on this website is copyright the respective owners/authors. DallasFortWorthInjuryLawyer.com / ShezadMalik.com makes no claim of copyright on such material.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Please do not include any confidential or sensitive information in a contact form, text message, or voicemail. The contact form sends information by non-encrypted email, which is not secure. Submitting a contact form, sending a text message, making a phone call, or leaving a voicemail does not create an attorney-client relationship.

Copyright © 2024, Fort Worth Personal Injury Lawyer Dr. Shezad Malik
JUSTIA Law Firm Blog Design